SAN FRANCISCO and SUZHOU, China, Oct. 26, 2019 /PRNewswire/ -- Adagene, Inc., a clinical stage biotech company with innovative ... Oncology (San Antonio, Texas), and consists of dose-escalation and dose-expansion phases ...
News
- Adagene Presents Its Lead Antibody Program, ADG106, at International Conferences
- San Antonio company develops new liquid bandage
San Antonio company develops new liquid bandage ... She said she was drawn to biotechnology after watching her father suffer with kidney disease ...
- BiOasis: Fiscal 2Q Earnings Snapshot
The biotech drug developer posted revenue of $148,300 in the period. Its adjusted revenue was $148,000. In the final minutes of trading on Friday, the ...
- Austin, San Antonio Office Markets Move Closer While Retaining Distinct Drivers
Defense, healthcare, oil and gas and the burgeoning markets of cybersecurity and biotech are driving absorption in San Antonio. New tenants are ...
- Anixa Biosciences Announces Collaboration with Urology San Antonio on Cchek(TM) Prostate ...
SAN JOSE, Calif., Oct. 25, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the ...